We are live on ! Find out more
SGYPW

Synergy Pharmaceuticals, Inc. - Warrants
SGYPW

Delisted

SGYPW was delisted on the 6th of December, 2016.

Back to rankings

2 hedge funds and large institutions have $600K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less funds holding

Funds holding: 3 → 2 (-1)

38% less capital invested

Capital invested by funds: $960K → $600K (-$360K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
APU
Alpine Partners USVI
U.S. Virgin Islands
-$280K
2
TRCT
Tower Research Capital (TRC)
New York
-$1.14K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$600K – – –
APU
2
Alpine Partners USVI
U.S. Virgin Islands
– -$280K -65,000 Closed
TRCT
3
Tower Research Capital (TRC)
New York
– -$1.14K -600 -94%

SGYPW Hedge Fund Activity: Q3 2013 in Review

2 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q3 2013, worth a combined $600K — down 38% from $960K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SGYPW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Alpine Partners USVI, exiting entirely with an estimated $280K sold.

  • 2 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q3 2013, down from 3 in Q2 2013.
  • Funds reported $600K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q3 2013, down 38% quarter-over-quarter.
  • 0 funds opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q3 2013 and 1 closed out, a net change of -1 holder.
  • The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q3 2013 was Alpine Partners USVI, an estimated $280K sold.

Based on aggregated 13F filings for Q3 2013.